Spectrum Pharmaceuticals Inc expected to post a loss of 19  cents a share - Earnings Preview

Spectrum Pharmaceuticals

10/05/2022 23:50

* Spectrum Pharmaceuticals Inc  SPPI.OQ   SPPI.O  is
expected
to show no change in quarterly revenue when it reports 
results on May 12. 
    * ​Refinitiv's mean analyst estimate for Spectrum
Pharmaceuticals
Inc is for a loss of 19 cents per share. For the same quarter
last year, the company reported a loss of 25 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Spectrum
Pharmaceuticals Inc is $4​, above​ its last closing price
of $0.83. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021              -0.21      -0.26     Missed  -21.5
 Sep. 30 2021  -0.28       -0.28      -0.21     Beat    25
 Jun. 30 2021  -0.25       -0.25      -0.32     Missed  -25.5​
 Mar. 31 2021  -0.30       -0.31      -0.25     Beat    20.6
 ​​Dec.                    -0.29      -0.29     Met     0
 31 2020                                                
 Sep. 30 2020  -0.35       -0.35      -0.37     Missed  -5.7​
 Jun. 30 2020  -0.29       -0.32      -0.28     Beat    11.4
 Mar. 31 2020  -0.34       -0.35      -0.36     Missed  -4
 This summary was machine generated May 10 at 22:50 GMT.  All
figures in US dollars  unless otherwise stated